Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses

被引:0
|
作者
M. Elise R. Graham
Robert D. Hart
Susan Douglas
Fawaz M. Makki
Devanand Pinto
Angela L. Butler
Martin Bullock
Matthew H. Rigby
Jonathan R. B. Trites
S. Mark Taylor
Rama Singh
机构
[1] Queen Elizabeth II Health Sciences Centre and Dalhousie University,Division of Otolaryngology
[2] NRC Human Health Therapeutics,Division of Anatomical Pathology
[3] Queen Elizabeth II Health Sciences Centre and Dalhousie University,undefined
关键词
Papillary thyroid cancer; MicroRNA; Serum testing; Biomarkers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses
    Graham, M. Elise R.
    Hart, Robert D.
    Douglas, Susan
    Makki, Fawaz M.
    Pinto, Devanand
    Butler, Angela L.
    Bullock, Martin
    Rigby, Matthew H.
    Trites, Jonathan R. B.
    Taylor, S. Mark
    Singh, Rama
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2015, 44
  • [2] miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses
    Yang, F.
    Zhang, H.
    Leng, X.
    Hao, F.
    Wang, L.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2018, 75 (01) : 43 - 45
  • [3] MicroRNA Profiling in Papillary Thyroid Cancer
    Armos, Richard
    Bojtor, Bence
    Papp, Marton
    Illyes, Ildiko
    Lengyel, Balazs
    Kiss, Andras
    Szili, Balazs
    Tobias, Balint
    Balla, Bernadett
    Piko, Henriett
    Illes, Anett
    Putz, Zsuzsanna
    Toth, Erika
    Takacs, Istvan
    Kosa, Janos P.
    Lakatos, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [4] Association of serum miR-375, miR-155 and miR-146b levels with distinguish of papillary thyroid cancer from benign thyroid masses among Iranian patients
    Gholam-Reza Mobini
    Homayon Yousefi
    Ali Shojaeian
    Mahmood Mirhoseini
    Mohammad-Reza Mahmoudian-Sani
    Egyptian Journal of Medical Human Genetics, 24
  • [5] Association of serum miR-375, miR-155 and miR-146b levels with distinguish of papillary thyroid cancer from benign thyroid masses among Iranian patients
    Mobini, Gholam-Reza
    Yousefi, Homayon
    Shojaeian, Ali
    Mirhoseini, Mahmood
    Mahmoudian-Sani, Mohammad-Reza
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2023, 24 (01)
  • [6] Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer
    Kwon, Hyemi
    Park, Se Eun
    Yun, Ji-Sup
    Park, Cheol-Young
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (02) : 396 - 406
  • [7] Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer
    Francesca Capriglione
    Antonella Verrienti
    Marilena Celano
    Valentina Maggisano
    Marialuisa Sponziello
    Valeria Pecce
    Agnese Gagliardi
    Laura Giacomelli
    Valerio Aceti
    Cosimo Durante
    Stefania Bulotta
    Diego Russo
    Endocrine, 2022, 75 : 185 - 193
  • [8] Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer
    Capriglione, Francesca
    Verrienti, Antonella
    Celano, Marilena
    Maggisano, Valentina
    Sponziello, Marialuisa
    Pecce, Valeria
    Gagliardi, Agnese
    Giacomelli, Laura
    Aceti, Valerio
    Durante, Cosimo
    Bulotta, Stefania
    Russo, Diego
    ENDOCRINE, 2022, 75 (01) : 185 - 193
  • [9] Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules
    Finley, DJ
    Arora, N
    Zhu, BX
    Gallagher, L
    Fahey, TJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07): : 3214 - 3223
  • [10] MicroRNA profiling of papillary thyroid carcinoma cell lines
    Smyth, P.
    Cahill, S.
    Denning, K.
    Li, J.
    Finn, S. P.
    Guenther, S.
    Henfry, R.
    O'Leary, J. J.
    Sheils, O.
    MODERN PATHOLOGY, 2007, 20 : 105A - 105A